PT-141 10MG
$59.00
PT-141, also known as Bremelanotide, is a heavily modified synthetic derivative of alpha-melanocyte-stimulating hormone designed for research use. It is a cyclic heptapeptide studied for its interaction with melanocortin receptors and related cellular signaling pathways.
In laboratory settings, PT-141 is supplied as a high-purity lyophilized powder and used to investigate melanocortin receptor activity and peptide–receptor interactions. It is intended exclusively for in vitro and experimental research applications and is not for human or veterinary use.
Description
PT-141, also called Bremelanotide (generic clinical name), is a heavily modified synthetic derivative of alpha-melanocyte-stimulating hormone.
Chemical Information
- Chemical Name: PT-141 (Bremelanotide)
- Molecular Formula: C₅₀H₆₈N₁₄O₁₀
- Molecular Weight: ~1,025.2 Da
- Peptide Length: 7 amino acids (cyclic peptide)
- Classification: Synthetic melanocortin receptor agonist peptide
- Purity: ≥99% (HPLC, research grade)
- Appearance: White to off-white lyophilized powder
- Net Content: 10 mg
Additional Information
- Sequence Description: Cyclic heptapeptide analogue of α-MSH with enhanced melanocortin receptor activity
- CAS Number: 189691-06-3
- Salt Form: Typically acetate or TFA (manufacturer dependent)
Storage Conditions
- Store lyophilized powder at –20 °C or below
- Protect from light, heat, and moisture
- Avoid repeated freeze–thaw cycles after reconstitution
Intended Use
- For research use only (RUO)
- Intended for in vitro and laboratory research applications
- Not for human or veterinary use
Additional information
| Size |
1MG (1000MCG) ,2MG (2000MCG) |
|---|
Reviews (0)
Related products
CagriSema 10MG/10MG
CagriSema is a high-purity dual-agonist research peptide blend combining cagrilintide (amylin analogue) and semaglutide (GLP-1 receptor agonist) for studies of metabolic signaling and receptor interaction. It is supplied as a white to off-white lyophilized powder and intended strictly for laboratory research use only.
This peptide blend supports research on glucose response, appetite models, and energy balance by enabling the study of combined GLP-1 and amylin pathway activity in controlled experimental settings.
CJC-1295 (no DAC) 5MG
CJC-1295 (No DAC), also known as Modified GRF (1-29), is a synthetic growth hormone-releasing hormone (GHRH) analogue used in laboratory research. It is supplied as a white to off-white lyophilized powder, typically in a 5 mg vial, with high purity (≥98 % HPLC verified) and is intended strictly for research use only.
Unlike DAC-modified versions, CJC-1295 without DAC has a shorter half-life, making it useful for studying pulsatile growth hormone release and receptor activity in controlled preclinical and experimental settings.
FOXO4-DRI
FOXO4-DRI (FOXO4 D-Retro-Inverso Peptide) is a synthetic research peptide composed of 27 D-amino acids with an approximate molecular weight of 5,350–5,400 Da and ≥99% purity. It is supplied as a white to off-white lyophilized powder in 5 mg or 10 mg quantities for laboratory research use.
Researchers use FOXO4-DRI to study cellular aging by examining the selective removal of senescent cells and its impact on tissue repair, regeneration, and longevity pathways through FOXO4–p53 interactions.
GLP-1SG 10MG
GLP-1SG (Glucagon-Like Peptide-1, Stabilized/Glycosylated or Super Gene variant) is a synthetic GLP-1–based peptide hormone analog consisting of approximately 30–31 amino acids, with a molecular weight of ~3,300–3,500 Da. It is supplied as a white to off-white lyophilized powder with ≥99% HPLC research-grade purity in 10 mg quantities.
GLP-1SG is designed to activate GLP-1 receptors and is modified for enhanced stability and resistance to enzymatic degradation. It is intended exclusively for in vitro and laboratory research use to support the study of metabolic pathways and is not for human or veterinary use.
GLP-3RT 12MG
GLP-3RT 12MG is a GGG tri-agonist research peptide that activates GLP-1, GIP, and glucagon receptors, enhancing basal metabolism while supporting appetite control and delayed gastric emptying. This multi-receptor activity provides a broader approach to obesity research compared to traditional GLP-1 agonists.
GLP-3RT is a synthetic GLP-based peptide analogue of approximately 30–35 amino acids with a molecular weight of ~3,500–4,200 Da and ≥99% research-grade purity. It is supplied as a white to off-white lyophilized powder in 12 mg vials for in vitro and laboratory research use only.
GLP-3RT 6MG
GLP-3RT is a GGG tri-agonist research peptide that targets GLP-1 and GIP receptors while also uniquely activating the glucagon receptor, distinguishing it from standard GLP-1 agonists. It has been evaluated in Phase 2 clinical studies, including trials focused on obesity and cardiovascular disease, such as TRIUMPH-3.
GLP-3RT is a synthetic GLP-based peptide analogue consisting of approximately 30–35 amino acids, with a molecular weight of ~3,500–4,200 Da and ≥99% HPLC research-grade purity. It is supplied as a white to off-white lyophilized powder in 6 mg quantities and is intended exclusively for in vitro and laboratory research use.
IGF-LR3 1MG
IGF-LR3 1MG is a synthetic long-acting analog of insulin-like growth factor-1, featuring an arginine substitution at position 3 and an extended N-terminal sequence. With a molecular weight of approximately 9,110 Da and ≥99% HPLC research-grade purity, it is supplied as a white to off-white lyophilized powder.
IGF-LR3 is designed to reduce IGF binding protein interaction and extend biological half-life, making it useful for in vitro and laboratory research applications. It should be reconstituted with acetic acid rather than bacteriostatic water and is intended strictly for research use only, not for human or veterinary use.
Melanotan II
Melanotan II is a synthetic melanocortin peptide used in laboratory research to study peptide–receptor interactions, cell signaling, and molecular communication. Its stable cyclic structure supports accurate and repeatable testing of how peptides influence cellular responses in controlled environments.
Researchers rely on Melanotan II for exploring protein activity, receptor affinity, and cellular adaptation under changing conditions. Supplied as a high-purity lyophilized powder, it delivers consistent performance for in vitro biochemical and molecular research and is intended strictly for research use only.
Reviews
There are no reviews yet.